Moleculent

Solna, Sweden

Moleculent is the Biotechnology Research company.

$26.0M raised

Apr 2026

Series A

Top Investors

ARCH Venture PartnersEIR VenturesRubicon Healthcare Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Moleculent raised?

Moleculent has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.

Who are Moleculent's investors?

Moleculent's investors include ARCH Venture Partners, EIR Ventures, Rubicon Healthcare Partners.

Where is Moleculent headquartered?

Moleculent is headquartered in Solna, Sweden.

What does Moleculent do?

Moleculent is the Biotechnology Research company.

What stage is Moleculent at?

Moleculent is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 30, 2026.

MLA

"Moleculent — Funding & Investors." VCBacked, April 30, 2026, https://www.vcbacked.co/company/moleculent. Accessed June 3, 2026.

APA

VCBacked. (2026). Moleculent — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/moleculent

Wikipedia (cite web)

{{cite web |title=Moleculent — Funding & Investors |url=https://www.vcbacked.co/company/moleculent |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 30, 2026.